Adverse events associated with molnupiravir: a real-world disproportionality analysis in food and drug administration adverse event reporting system

Adverse events associated with molnupiravir: a real-world disproportionality analysis in food and drug administration adverse event reporting system

Molnupiravir, an urgently approved drug during the Coronavirus Disease 2019 (COVID-19) pandemic, serves as the basis for our study, which relies on the Food and Drug Administration Adverse Event Reporting System (FAERS). The objective is to extract adverse event (AE) signals associated with molnupir...

Full description

Bibliographic Details
Main Authors: Yankun Liang, Lin Ma, Yuting Wang, Jingping Zheng, Ling Su, Jun Lyu
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-10-01
Series:Frontiers in Pharmacology
Subjects:
molnupiravir
pharmacovigilance
coronavirus disease 2019
food and drug administration adverse event reporting system
adverse events
safety
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2023.1253799/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2023.1253799/full

Similar Items